Innovative Medicines & Omics [IMO] publishes rigorously peer-reviewed and high-quality original research articles and authoritative reviews that focus on pharmacy and omics in the field of animal and human health. 

Now we are currently looking for 1-2 Associate Editors for our journal. This is an opportunity to exchange with and learn from experts in the same field.

IMO is an international, double-blind peer-reviewed, quick-refereeing open-access journal. The journal was launched in April, 2023 by cooperating with Beijing University of Chemical Technology by Singapore AccScience Publishing (ASP, https://accscience.com/).  We have already established a very good Editorial Board: https://accscience.com/journal/IMO/about/editorial_board

We encourage applications from researchers with a background in a range of subject areas (https://accscience.com/journal/IMO/about/aims_scope).Should you decide to serve on this position, you would be responsible for some of the following tasks depending on your availability:

- Assisting the Editor-in-Chief in journal management;
- Inviting additional scientists to join the Editorial Board;
- Recommending timely topics and suggesting potential guest editors;
- Publishing one paper per year, free of charge, in open access;
- Promoting the journal.

As we provide a low-cost publishing service in open access format, we unfortunately cannot additionally pay an honorarium. The term of the Associate Editor membership is three years and could then be renewed.

We believe that your expertise together with our rigorous editorial policies can build a high-standard journal specifically dedicated to Pharmacy and Omics research. If you are interested in becoming an Associate Editor for IMO, please send your full academic CV and a short cover letter that details your interest and enthusiasm for the position to imo.office@accscience.sg <imo.office@accscience.sg>.

Welcome to join us!

Innovative Medicines & Omics Editorial Office